market access

News

A NICE yes for latest immunotherapy Bavencio

NICE has recommended Merck KGaA and Pfizer’s Bavencio in previously treated metastatic Merkel Cell Carcinoma, a rare and aggressive form of skin cancer.

News

NHS drug deal could fund vital cystic fibrosis research - Ve...

Vertex wants long-term funding for CF research

News

Pediatrician makes vaccination to small boy

Call for new restrictions on UK vaccine prices

Proposals also include fresh attack on drug prices

News

Eisai disappointed after NICE rejects earlier use for breast...

NICE says no to Halaven in second line breast cancer

News

Vertex negotiating with NHS England on cystic fibrosis drug ...

Vertex is trying reach a deal with NHS England to give patients access to all its approved cystic fibrosis (CF) drugs - and hopes it could also fund further drugs in the pipeline.

News

NICE recommends funding for three thyroid cancer drugs

Eisai's drug finally funded after two year delay

A NICE yes for latest immunotherapy Bavencio

NHS drug deal could fund vital cystic fibrosis research - Ve...

Call for new restrictions on UK vaccine prices

Eisai disappointed after NICE rejects earlier use for breast...

Vertex negotiating with NHS England on cystic fibrosis drug ...

NICE recommends funding for three thyroid cancer drugs

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks